Established, emerging and future applications of FDG-PET/CT in the uterine cancer

K. Kitajima, K. Murakami, Y. Kaji, S. Sakamoto, K. Sugimura

Research output: Contribution to journalReview article

24 Citations (Scopus)

Abstract

Integrated positron emission tomography/computed tomography (PET/CT) with 2-[18F]fluoro-2-deoxy-d-glucose (FDG) is a useful technique to acquire both glucose metabolic and anatomic imaging data using a single device in a single diagnostic session and has opened a new field in clinical oncologic imaging. FDG-PET/CT has been used successfully for the staging, optimization of treatment, re-staging, therapy monitoring, and prognostic prediction of uterine cervical cancer and endometrial cancer as well as various malignant tumours. The present review discusses the current role of FDG-PET/CT in the management of uterine cancer, discussing its usefulness and limitations in the imaging of these patients.

Original languageEnglish
Pages (from-to)297-307
Number of pages11
JournalClinical Radiology
Volume66
Issue number4
DOIs
Publication statusPublished - 2011 Apr 1

    Fingerprint

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Kitajima, K., Murakami, K., Kaji, Y., Sakamoto, S., & Sugimura, K. (2011). Established, emerging and future applications of FDG-PET/CT in the uterine cancer. Clinical Radiology, 66(4), 297-307. https://doi.org/10.1016/j.crad.2010.07.012